{"id":{"repo_id":"bradford","oai_identifier":"oai:bradscholars.brad.ac.uk:10454/20841"},"canonical_url":"https://search.dev.ndltd.org/etd/bradford/oai:bradscholars.brad.ac.uk:10454/20841","repository":{"repo_id":"bradford","name":"University of Bradford","base_url":"https://bradscholars.brad.ac.uk/oai/request"},"display":{"title":"Repurposing doxorubicin and digoxin as novel treatment options for Pulmonary Arterial Hypertension (PAH)","abstract":"","abstract_html":null,"abstract_has_math":false,"creators":["Mohammed, Nura S."],"institution":"University of Bradford","degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":["Nasim, Talat","Gopalan, Rajendran","Assi, Khaled H."],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-07-24T01:15:46Z","subjects":["Doxorubicin","Digoxin","ERK1","ABL1","IGF1R","Bone morphogenic protein (BMP)","Transforming growth factor (TGFβ)","Pulmonary arterial hypertension (PAH)"],"languages":["en"],"rights":["<a rel=\"license\" href=\"http://creativecommons.org/licenses/by-nc-nd/3.0/\"><img alt=\"Creative Commons License\" style=\"border-width:0\" src=\"http://i.creativecommons.org/l/by-nc-nd/3.0/88x31.png\" /></a><br />The University of Bradford theses are licenced under a <a rel=\"license\" href=\"http://creativecommons.org/licenses/by-nc-nd/3.0/\">Creative Commons Licence</a>."],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"https://bradscholars.brad.ac.uk/handle/10454/20841","outbound_label":"Repository record","outbound_source":"dc:identifier.uri"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Nasim, Talat","Gopalan, Rajendran","Assi, Khaled H."]},{"key":"dc:creator","label":"Author","values":["Mohammed, Nura S."]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2026-03-18T13:04:00Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2026-03-18T13:04:00Z"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["School of Pharmacy and Medical Sciences. Faculty of Life Sciences"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Bradford"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["doctoral"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["PhD"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Doxorubicin","Digoxin","ERK1","ABL1","IGF1R","Bone morphogenic protein (BMP)","Transforming growth factor (TGFβ)","Pulmonary arterial hypertension (PAH)"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en"]},{"key":"dc:rights","label":"Dc Rights","values":["<a rel=\"license\" href=\"http://creativecommons.org/licenses/by-nc-nd/3.0/\"><img alt=\"Creative Commons License\" style=\"border-width:0\" src=\"http://i.creativecommons.org/l/by-nc-nd/3.0/88x31.png\" /></a><br />The University of Bradford theses are licenced under a <a rel=\"license\" href=\"http://creativecommons.org/licenses/by-nc-nd/3.0/\">Creative Commons Licence</a>."]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://bradscholars.brad.ac.uk/handle/10454/20841"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:title","label":"Title","values":["Repurposing doxorubicin and digoxin as novel treatment options for Pulmonary Arterial Hypertension (PAH)"]}]}],"canonical_facts":{"dc:contributor.advisor":["Nasim, Talat","Gopalan, Rajendran","Assi, Khaled H."],"dc:creator":["Mohammed, Nura S."],"dc:date.accessioned":["2026-03-18T13:04:00Z"],"dc:date.available":["2026-03-18T13:04:00Z"],"dc:identifier.uri":["https://bradscholars.brad.ac.uk/handle/10454/20841"],"dc:language.iso":["en"],"dc:publisher.department":["School of Pharmacy and Medical Sciences. Faculty of Life Sciences"],"dc:publisher.institution":["University of Bradford"],"dc:rights":["<a rel=\"license\" href=\"http://creativecommons.org/licenses/by-nc-nd/3.0/\"><img alt=\"Creative Commons License\" style=\"border-width:0\" src=\"http://i.creativecommons.org/l/by-nc-nd/3.0/88x31.png\" /></a><br />The University of Bradford theses are licenced under a <a rel=\"license\" href=\"http://creativecommons.org/licenses/by-nc-nd/3.0/\">Creative Commons Licence</a>."],"dc:subject":["Doxorubicin","Digoxin","ERK1","ABL1","IGF1R","Bone morphogenic protein (BMP)","Transforming growth factor (TGFβ)","Pulmonary arterial hypertension (PAH)"],"dc:title":["Repurposing doxorubicin and digoxin as novel treatment options for Pulmonary Arterial Hypertension (PAH)"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["doctoral"],"dc:type.qualificationname":["PhD"]},"updated_at":"2026-07-24T01:15:46Z"}